Duloxetine Hydrochloride
Product Images NDC 50090-3317

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Duloxetine Hydrochloride (NDC 50090-3317). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1.jpg (Figure1)

The given text describes a graph indicating relapse rates for patients undergoing treatment with a placebo versus those receiving Duloxetine medication over a certain period. The horizontal axis representing "Time from Randomization to Relapse (Days)" ranges from 0 to 250 days, while the vertical axis represents the "Proportion of Patients with Relapse" ranging from 0.6 to 0.8. The graph displays two plots, one each for the placebo and Duloxetine treatments, respectively.*

FDA Label Image

Figure2.jpg (Figure2)

This is a graph displaying the proportion of patients with relapse over time from randomization in a clinical trial for a treatment compared to a placebo. The treatment being tested is duloxetine. The X-axis represents time in days and ranges from 0 to 300. The Y-axis represents the proportion of patients and ranges from 0 to 10%.*

FDA Label Image

Figure3.jpg (Figure3)

FDA Label Image

Figure4.jpg (Figure4)

Not available. The text appears to be a mixture of random characters and numbers, with no meaningful sentence or description.*

FDA Label Image

Figure5.jpg (Figure5)

This appears to be a graph displaying the percent improvement in pain from baseline while using placebo and duloxetine at 60/120 mg once daily. It is not clear what the data is specifically referring to, so further context is not available.*

FDA Label Image

Figure6.jpg (Figure6)

FDA Label Image

Figure7.jpg (Figure7)

This is a graph showing the percentage of patients who improved after taking either a placebo or Duloxetine 60/120 mg once daily. The graph also shows the percentage of improvement in pain from baseline.*

FDA Label Image

Dulostructure (Dulostructure)

FDA Label Image

Label Image (Lbl500903317)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.